Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2a ataluren study in nonambulatory patients with nonsense-mutation-mediated Duchenne/Becker muscular dystrophy
2009-013169-24Phase 2Terminated
- Sponsor
- PTC Therapeutics, Inc.
- Start
- Mar 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ataluren in Duchenne muscular dystrophy (DMD), Becker muscular dystrophy (BMD), sponsored by PTC Therapeutics, Inc.. Started Mar 2010; status: terminated.
02
Drugs
ataluren
03
Conditions
Duchenne muscular dystrophy (DMD)Becker muscular dystrophy (BMD)
Beyond the preview
Go deeper on 2009-013169-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-013169-24.